¡Ya estamos en ! Descubre más
14.61 USD
-0.16
1.08%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
14.61
0.00
0%
1 día
-1.08%
5 días
5.49%
1 mes
4.88%
3 meses
-12.2%
6 meses
8.79%
En lo que va del año
-4.26%
1 año
-30.86%
5 años
-65.16%
10 años
-27.39%
 

Acerca de: Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Empleados: 16,000

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 63.6%
Neutral 36.4%
Negativo 0%
Positivo
Zacks Investment Research
hace 23 días
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
Positivo
Seeking Alpha
hace 23 días
Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment
I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also simplifies its business and boosts its valuation appeal as a short-stay surgical pure-play. I see significant upside from the $60B inpatient-to-outpatient migration, supported by robust practitioner recruitment and disciplined acquisition strategy.
Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment
Neutral
GlobeNewsWire
hace 29 días
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced it has completed the previously announced sale of its ownership interests in its Idaho Falls facilities to Intermountain Health.
Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
Positivo
The Motley Fool
el mes pasado
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
Positivo
Zacks Investment Research
hace 2 meses
Likely ETF & Stock Winners From July Jobs Report
Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.
Likely ETF & Stock Winners From July Jobs Report
Neutral
Seeking Alpha
hace 2 meses
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
Neutral
MarketBeat
hace 2 meses
Surgery Partners Q2 Earnings Call Highlights
Surgery Partners NASDAQ: SGRY reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its Idaho Falls market operations to Intermountain Health.
Surgery Partners Q2 Earnings Call Highlights
Positivo
Zacks Investment Research
hace 2 meses
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Positivo
Zacks Investment Research
hace 2 meses
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?
Positivo
Benzinga
hace 2 meses
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
Surgery Partners, Inc. (NASDAQ:SGRY) stock is trading higher on Friday as the company announced a significant transaction involving the sale of its ownership interests in Idaho Falls facilities to Intermountain Health.
Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth
Gráficos de precios implementados con Lightweight Charts™